Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier NCT05232825; submitted: January 27, 2022; first patient enrolled: May 3, 2022; available at: clinicaltrials.gov/study/NCT05232825?term=NCT05232825&rank=1.
Authors
- Ben Townsend (ORCID: https://orcid.org/0000-0002-3666-0719)
- Michal Dufek (ORCID: https://orcid.org/0000-0003-3773-4510)
- Diego Centonze (ORCID: https://orcid.org/0000-0002-8390-8545)
- Heidemarie Kletzl (ORCID: https://orcid.org/0000-0001-8129-2196)
- Ewa Krzystanek (ORCID: https://orcid.org/0000-0003-4441-3088)
- Oscar Bortolami (ORCID: https://orcid.org/0000-0002-4346-9672)
- Susanne Clinch (ORCID: https://orcid.org/0000-0002-3458-0117)
- Lawrence Goldstick
- Krzysztof Selmaj (ORCID: https://orcid.org/0000-0003-1213-7218)
- Hans‐Martin Schneble (ORCID: https://orcid.org/0000-0001-5828-2336)
- Caroline Giacobino
- Scott D. Newsome (ORCID: https://orcid.org/0000-0002-5284-4681)
- Dusanka Zecevic (ORCID: https://orcid.org/0000-0001-6719-9710)
- Carlo Pozzilli (ORCID: https://orcid.org/0000-0002-6360-4798)
- Catarina Figueiredo (ORCID: https://orcid.org/0000-0002-5404-782X)
- Yun‐An Shen
- Gurpreet Deol Bhullar
Institutions
- Roche (Switzerland) (CH)
- Johns Hopkins University (US)
- Medical University of Silesia (PL)
- Masaryk University (CZ)
- Johns Hopkins Medicine (US)
- Istituto Neurologico Mediterraneo (IT)
- Roche (Canada) (CA)
- Roche (United Kingdom) (GB)
- St. Anne's University Hospital Brno (CZ)
- University of Warmia and Mazury in Olsztyn (PL)
- University of Cincinnati (US)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1212/wnl.0000000000213574
- Citations
- 5
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.36